• Novartis’s Gilenya® got Approved by FDA for Pediatric Relapsing Multiple Sclerosis

    Share Now4sharesFacebook4Twitter0Google+Pinterest0Novartis’s Gilenya® got Approved by FDA for Pediatric Relapsing Multiple Sclerosis By: Novartis News Novartis announced that the US Food and Drug Administration (FDA) has approved Gilenya® (fingolimod) for the treatment of children and adolescents 10 to less than 18 years of age with relapsing forms of multiple sclerosis (RMS), [..]

  • FDA Grants Priority Review to Genentech’s Cancer Immunotherapy Tecentriq

    Share Now3sharesFacebook3Twitter0Google+Pinterest0FDA Grants Priority Review to Genentech’s Cancer Immunotherapy Tecentriq By: Genentech News Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) and granted Priority Review for TECENTRIQ® (atezolizumab), in [..]

  • First-in-World Robot-Assisted Spinal Surgery

    Share Now2sharesFacebook2Twitter0Google+Pinterest0First-in-World Robot-Assisted Spinal Surgery By: University of Pennsylvania School of Medicine Noah Pernikoff is back to his life in New York City after becoming the first patient in the world to undergo a complex three-part, robotic-assisted surgery. The robotic arms made it possible for the multidisciplinary team at Penn to [..]

  • Could robots be counsellors? Early research shows positive user experience

    Share Now2sharesFacebook2Twitter0Google+Pinterest0Could Robots be Counsellors? Early Research Shows Positive User Experience By: University of Plymouth News New research has shown for the first time that a social robot can deliver a ‘helpful’ and ‘enjoyable’ motivational interview (MI) – a counselling technique designed to support behaviour change.  Many participants in the University [..]

  • Tafinlar® + Mekinist® of Novartis Receives FDA Approval for the Treatment of BRAF V600-Mutant Melanoma

    Share Now5sharesFacebook5Twitter0Google+Pinterest0Tafinlar® + Mekinist® of Novartis Receives FDA Approval for the Treatment of BRAF V600-Mutant Melanoma By: Novartis News Novartis announced that the US Food and Drug Administration (FDA) has approved Tafinlar® (dabrafenib) in combination with Mekinist® (trametinib) for the adjuvant treatment of patients with melanoma with BRAF V600E or V600K mutations, [..]

  • Novartis Receives Second FDA Approval for Kymriah® to Treat B-cell Lymphoma

    Share Now48sharesFacebook47Twitter1Google+Pinterest0Novartis Receives Second FDA Approval for Kymriah® to Treat B-cell Lymphoma By: Novartis News Novartis today announced the US Food and Drug Administration (FDA) has approved Kymriah® (tisagenlecleucel) suspension for intravenous infusion for its second indication – the treatment of adult patients with relapsed or refractory (r/r) large B-cell lymphoma after [..]

  • First Revolutionary Contact Lens Innovation of J&J Received Clearance From US-FDA

    Share Now1sharesFacebook1Twitter0Google+Pinterest0First Revolutionary Contact Lens Innovation of J&J Received Clearance From US-FDA By: Johnson & Johnson News Johnson & Johnson Vision today announced ACUVUE OASYS® with Transitions® Light Intelligent Technology™ first of its kind contact lens that provides wearers with vision correction and a dynamic photochromic filter that helps to continuously balance [..]

  • FDA Permits Marketing of Artificial Intelligence-Based IDx-DR for Detection of Diabetic Retinopathy 

    Share Now1sharesFacebook1Twitter0Google+Pinterest0FDA Permits Marketing of Artificial Intelligence-Based IDx-DR for Detection of Diabetic Retinopathy  By: FDA News The U.S. Food and Drug Administration today permitted marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy in adults who have diabetes. [..]

  • Breakthrough Made in Atomically Thin Magnets

    Share Now2sharesFacebook2Twitter0Google+Pinterest0Breakthrough Made in Atomically Thin Magnets  By: Syl Kacapyr | Cornell News Cornell researchers have become the first to control atomically thin magnets with an electric field, a breakthrough that provides a blueprint for producing exceptionally powerful and efficient data storage in computer chips, among other applications. The research is [..]

  • New Test Kit for Personalized, Precise Cancer Therapy

    Share Now8sharesFacebook7Twitter1Google+Pinterest0New Test Kit for Personalized, Precise Cancer Therapy   A team of scientists led by Professor Lim Chwee Teck, Principal Investigator at the Mechanobiology Institute, Singapore (MBI) and the Department of Biomedical Engineering at the National University of Singapore (NUS) and NUS PhD graduate Dr Khoo Bee Luan, has [..]

  • Novel Chip for Fast and Accurate Disease Detection at Low Cost

    Share Now2sharesFacebook2Twitter0Google+Pinterest0Novel Chip for Fast and Accurate Disease Detection at Low Cost By: NYU News A novel invention by a team of researchers from the National University of Singapore (NUS) holds promise for a faster and cheaper way to diagnose diseases with high accuracy. Professor Zhang Yong from the Department [..]

  • Greener and Cheaper Technique for Biofuel Production

    Share Now8sharesFacebook8Twitter0Google+Pinterest0Greener and Cheaper Technique for Biofuel Production By: NYU News A team of engineers from the National University of Singapore (NUS) recently discovered that a naturally occurring bacterium, Thermoanaerobacterium thermosaccharolyticum TG57, isolated from waste generated after harvesting mushrooms, is capable of directly converting cellulose, a plant-based material, to biobutanol. A research [..]

shares